# Study of Serum Testosterone Levels in Non-dosed Females After Secondary Exposure

> **NCT00998933** · PHASE1 · COMPLETED · sponsor: **Solvay Pharmaceuticals** · enrollment: 24 (actual)

## Conditions studied

- Hypogonadism

## Interventions

- **DRUG:** Testosterone gel 1.62%

## Key facts

- **NCT ID:** NCT00998933
- **Lead sponsor:** Solvay Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-10
- **Primary completion:** 2009-10
- **Final completion:** 2009-10
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2009-11-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00998933

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00998933, "Study of Serum Testosterone Levels in Non-dosed Females After Secondary Exposure". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00998933. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*